Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

22.07
Delayed Data
As of 2:28pm ET
 -1.46 / -6.20%
Today’s Change
15.20
Today|||52-Week Range
35.00
-22.43%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close23.53
Today’s open23.36
Day’s range21.79 - 23.48
Volume94,746
Average volume (3 months)135,288
Market cap$502.7M
Dividend yield--
Data as of 2:28pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)+30.72%
Earnings growth (this year)-12.39%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.98

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-1.28-9.84%
PDLIPDL BioPharma Inc-0.07-2.44%
ARRYArray Biopharma Inc-0.17-4.93%
SGNTSagent Pharmaceutica...-0.76-5.06%
Data as of 2:46pm ET, 06/27/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$35.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts

Partner Offers

Search for Jobs